EUVIMEDEUVIMED entdecken
Crossref

Anticonvulsant hypersensitivity syndrome or drug rash with eosinophilia and systemic symptoms (DRESS) induced by anticonvulsants

Cristina Vlaicu

Alergologia · 2017

DOI: 10.26416/aler.1.1.2017.1242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alergologia, 2017. Verfasst von Cristina Vlaicu.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anticonvulsant hypersensitivity syndrome (AHS)/DRESS induced by anticonvulsants (ACs) is a rare, but severe and potentially fatal adverse reaction that occurs in patients who are treated with classical aromatic anticonvulsants (AAs) (phenytoin, carbamazepine and phenobarbital) as well as with some of the new ACs. Covered fields. AHS is a disease often difficult to diagnose, with high variability in its clinical presentation. The usual presentation is rash associated with fever and internal organ dysfunction. Symptoms usually occur between 2 and 8 weeks after starting treatment. A type IV hypersensitivity mechanism has been proposed, but viral infections, particularly herpes virus 6, have been shown to play a role. Individuals with specific HLA haplotypes are predisposed to develop this syndrome when exposed to certain medications. In vivo (patch test) and in vitro tests (lymphocyte transformation test) may be useful for the etiologic diagnosis of AHS. Management of AHS consists in its recognition, discontinuation of the causative AC, and the use of systemic corticosteroids. A 40-80% incidence of cross-reactivity between different AAs has been reported. Non-aromatic ACs are considered safe in these patients, but sometimes choosing an alternative AC may be difficult.

Conclusions

Given the high variability in the clinical presentation of AHS, physicians should have a high index of suspicion in AC-treated patients experiencing cutaneous manifestations and internal organ dysfunction. Early recognition of AHS and withdrawal of the causative AC therapy are essential for the treatment and for a successful outcome.

Zitieren

APA

Vlaicu, C. (2017). Anticonvulsant hypersensitivity syndrome or drug rash with eosinophilia and systemic symptoms (DRESS) induced by anticonvulsants. Alergologia. https://doi.org/10.26416/aler.1.1.2017.1242

Vancouver

Vlaicu C. Anticonvulsant hypersensitivity syndrome or drug rash with eosinophilia and systemic symptoms (DRESS) induced by anticonvulsants. Alergologia. 2017. doi:10.26416/aler.1.1.2017.1242

BibTeX
@article{Vlaicu2017,
  author = {Vlaicu, Cristina},
  title = {Anticonvulsant hypersensitivity syndrome or drug rash with eosinophilia and systemic symptoms (DRESS) induced by anticonvulsants},
  journal = {Alergologia},
  year = {2017},
  doi = {10.26416/aler.1.1.2017.1242}
}
Kostenlos starten →